September 10, 2007 - Siemens Medical Solutions’ Molecular Imaging Division is showcased its Inveon modular system that allows users to combine positron emission tomography (PET), single photon emission computed tomography (SPECT) and computed tomography (CT) acquisition systems in one unit, at the Joint AMI/SMI Molecular Imaging Conference, Sept. 7 to Sept. 11, in Providence, RI.
The system reportedly delivers the industry's highest PET resolution and sensitivity and boasts a suite of research tools that improve the workflow of basic research. According to the company, these tools are said to help speed the drug development process as they enable researchers to identify specific biological processes, monitor the efficacy of compounds, and measure the effects of disease progression over time.
Siemens will demonstrated its other clinical image acquisition products at the show. These systems were recently enhanced with the introduction of HD PET, which adds high-definition imaging to the Biograph TruePoint family of hybrid PET CT systems. The technology provides a unique, uniform resolution throughout the entire field of view. HD PET eliminates the effect whereby the image loses resolution further out from the center of the field of view. This increased diagnostic accuracy can help physicians better detect peripheral lesions. This improved 2-millimeter resolution enables physicians to clearly visualize the smallest of lesions from the center to the edges of the field of view.
Siemens also offers software to improve the workflow of those reading clinical images. For instance, oncology departments can benefit from syngo TrueD software, which allows users to fuse and compare up to three PET CT or single photon emission computed tomography and CT (SPECT CT) studies simultaneously. Using this method to examine anatomical or functional changes as a result of cancer therapy allows physicians to monitor progress over a course of treatment and to possibly make more timely decisions as to the effectiveness of treatment sooner. Patients who lack significant response may be moved to alternative therapies that could be more successful. In the neurological imaging environment, sophisticated computer-aided brain function analysis tools like syngo Scenium facilitate neurological evaluation by enabling automatic correlation of a patient study with an average brain scan for assessment of abnormalities.
For more information: www.usa.siemens.com/medical